Cited by 131MRI in cancer diagnosisRadiomics and Machine Learning in Medical ImagingImage Retrieval and Classification Techniques

Dynamic contrast‐enhanced MRI texture analysis for pretreatment prediction of clinical and pathological response to neoadjuvant chemotherapy in patients with locally advanced breast cancer

Teruel, Jose R., Heldahl, Mariann G., Goa, Pål E., Pickles, Martin, Lundgren, Steinar, Bathen, Tone F., Gibbs, Peter·2014·NMR in Biomedicine

Abstract

The aim of this study was to investigate the potential of texture analysis, applied to dynamic contrast‐enhanced MRI (DCE‐MRI), to predict the clinical and pathological response to neoadjuvant chemotherapy (NAC) in patients with locally advanced breast cancer (LABC) before NAC is started. Fifty‐eight patients with LABC were classified on the basis of their clinical response according to the Response Evaluation Criteria in Solid Tumors (RECIST) guidelines after four cycles of NAC, and according to their pathological response after surgery. T1‐weighted DCE‐MRI with a temporal resolution of 1 min was acquired on a 3‐T Siemens Trio scanner using a dedicated four‐channel breast coil before the onset of treatment. Each lesion was segmented semi‐automatically using the 2‐min post‐contrast subtracted image. Sixteen texture features were obtained at each non‐subtracted post‐contrast time point using a gray level co‐occurrence matrix. Appropriate statistical analyses were performed and false discovery rate‐based q values were reported to correct for multiple comparisons. Statistically significant results were found at 1–3 min post‐contrast for various texture features for the prediction of both the clinical and pathological response. In particular, eight texture features were found to be statistically significant at 2 min post‐contrast, the most significant feature yielding an area under the curve (AUC) of 0.77 for response prediction for stable disease versus complete responders after four cycles of NAC. In addition, four texture features were found to be significant at the same time point, with an AUC of 0.69 for response prediction using the most significant feature for classification based on the pathological response. Our results suggest that texture analysis could provide clinicians with additional information to increase the accuracy of prediction of an individual response before NAC is started. Copyright © 2014 John Wiley & Sons, Ltd.

Integrity signals

Registry

Crossref · 10.1002/nbm.3132

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • A study of 58 women who underwent treatment for locally advanced breast cancer suggested that texture analysis of dynamic contrast-enhanced MR imaging could help predict response to neoadjuvant chemotherapy before its initiation.

    “More recently, a study of 58 women who underwent treatment for locally advanced breast cancer suggested that texture analysis of dynamic contrast-enhanced MR imaging could help predict response to neoadjuvant chemotherapy before its initiation (59).”

    From Radiomics: Images Are More than Pictures, They Are Data (2016) · cites this paper as [59]

The citation lists haven’t been fetched yet

References 37 · Cited by 131

Authors
Teruel, J. R., Heldahl, M. G., Goa, P. E., Pickles, M., Lundgren, S., Bathen, T. F., & Gibbs, P.
Affiliations
  • Norwegian University of Science and Technology (NO)
  • University of Hull (GB)
Corresponding author
Teruel, Jose R.
Venue
NMR in Biomedicine
Publisher
Wiley
Published
2014-05-20
Volume
27
Issue
8
Pages
887-896
ISSN
  • 0952-3480 (ISSN-L)
  • 1099-1492
OpenAlex
W1578777125
Cited by
131
References
37
Citations by year
2026: 3 · 2025: 4 · 2024: 2 · 2023: 5 · 2022: 19 · 2021: 17 · 2020: 19 · 2019: 19 · 2018: 16 · 2017: 16 · 2016: 8 · 2015: 3
FWCI
7.03
Type
journal article
Language
en
Open access
closed
Locations
  • NMR in Biomedicine (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Central Norway Regional Health Authority (RHA)
  • Liaison Committee between the RHA and the Norwegian University of Science and Technology (NTNU)
  • NTNU Strategic Area of Medical Technology
Topics
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › MRI in cancer diagnosis
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Radiomics and Machine Learning in Medical Imaging
  • Physical Sciences › Computer Science › Computer Vision and Pattern Recognition › Image Retrieval and Classification Techniques
Keywords
dynamic contrast-enhanced MRI, texture analysis, locally advanced breast cancer, neoadjuvant chemotherapy, treatment response prediction, pathological response, clinical response, gray level co-occurrence matrix, pre-treatment imaging
MeSH terms
Adult, Aged, Aged, 80 and over, Breast Neoplasms, Contrast Media, Female, Humans, Image Processing, Computer-Assisted, Magnetic Resonance Imaging, Middle Aged, Neoplasm Staging, Treatment Outcome, Neoadjuvant Therapy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review